
Key Focus:
IMMUNOLOGY +
ANTIBODY
Empowering Immunology & Antibody Discovery with Genomic Insight
At AUGenomics, we deliver high-resolution next-generation sequencing (NGS) services that drive breakthrough discoveries in immunology and therapeutic antibody development. Our advanced platforms give researchers the ability to deeply profile immune repertoires, unraveling the complexities of immune responses with unparalleled precision.
Whether you’re studying B-cell or T-cell populations, identifying novel antibodies, or exploring immune system dynamics, our NGS solutions provide the comprehensive data needed to accelerate your research. From early discovery through clinical development, AUGenomics helps you navigate the full spectrum of immune profiling.
01
Sequence full antibody repertoires for rare and potent candidate discovery
02
Analyze TCR/BCR diversity, clonality, and dynamics
03
Investigate immune responses to vaccines, infections, or therapies
04
Rapidly screen large antibody libraries for lead identification
Faster Insights
We are revolutionizing the way researchers study the immune system and identify therapeutic antibodies. Through NGS, comprehensive analyses of immune repertoires can be conducted, providing a detailed understanding of the diversity and dynamics of immune cell populations. This technology enables the identification of rare and potent antibodies with specificity for various pathogens or disease targets. By sequencing antibody repertoires, we can help you uncover the genetic information underlying effective immune responses, facilitating the design of more targeted and efficacious immunotherapies. NGS has accelerated antibody discovery processes by allowing the rapid screening of large antibody libraries and enhancing the identification of candidates for drug development. The application of NGS in immunology not only expedites the discovery of novel antibodies but also enhances our understanding of immune system function, paving the way for the development of innovative and personalized immunotherapeutic approaches.